Please login to the form below
antimicrobial
This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
New report reveals antibiotic underdosing could be leading cause of AMR in UK
A new report conducted by the office of Baroness Bennett of Manor Castle has revealed an underdelivery of IV antibiotics, which could be a leading cause of antimicrobial resistance (AMR) in ... Without suitable antimicrobials to treat infections,
Latest news
-
First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
Additionally, other areas included mental health, tuberculosis, HIV, malaria, maternal and child health, ageing, vector-borne diseases including dengue fever, antimicrobial resistance, emerging infectious diseases and neglected tropical diseases.
-
Study finds AI detects AMR faster than gold-standard testing
Published in Communications Biology, a combination of fluorescence microscopy and AI was successful in detecting antimicrobial resistance (AMR). ... sectors to fight resistance and improve antimicrobial use in humans around the world.
-
World AMR Awareness Week to focus on urgent actions needed to prevent AMR
This AMR Awareness Week, leaders and communities across several sectors will work to preserve antimicrobials and protect the health of people, animals, plants and the environment. ... Currently, the misuse and overuse of antimicrobials is one of the
-
National surveillance data reveals increase in antibiotic resistant infections in England
Professor Jenny Harries, chief executive of UKHSA, said: "Antimicrobial resistance (AMR) is not a crisis of the future, but one that is very much with us right now… Unless action is
-
UK antibiotic subscription model found by OHE as key to supporting investment
The World Health Organization has declared antimicrobial resistance (AMR), when bacteria, viruses, fungi and parasites become resistant to antimicrobials, as one of the top ten threats to global public health. ... The OHE report, Proposals for a Novel UK
More from news
Approximately 78 fully matching, plus 81 partially matching documents found.
Latest Intelligence
-
Man vs microbe: the fight against antimicrobial resistance
Current Health Technology Assessment (HTA) frameworks and processes do not capture and assess the true value of antimicrobials that can address resistance. ... Action across Europe. To address these challenges, policymakers are looking for ways to
-
Resisting the resistance
Overuse and inappropriate prescribing of antimicrobials have led to the evolution of resistance in many pathogens – and with just a single new antimicrobial discovered in the last 36 years, available treatment ... Genomic data can support doctors in
-
Tuberculosis – why it remains a major global public health challenge
The five antimicrobial agents to be evaluated under the JDA, and the organisations contributing them, include:.
-
Why diagnostics investments are crucial to win the AMR battle
AMR Action Fund’s recent backing of Basel-based BioVersys to develop new antimicrobial agents is an exciting step for the $1bn fund. ... In 2019, nearly five million deaths were associated with bacterial antimicrobial resistance.
-
World Antimicrobial Awareness Week 2022
This year’s annual World Antimicrobial Awareness Week (WAAW), ran from 18 to 24 November and focused on improving awareness of antimicrobial resistance (AMR) and encouraging the responsible use of antibiotics ... Marking the conclusion of the week was
More from intelligence
Approximately 8 fully matching, plus 26 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
resistance, which is a part of the broader issue of antimicrobial resistance.
-
IFPMA names new communications director
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
-
Destiny Pharma appoints new CEO
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
-
New health ministers and re-appointments after reshuffle
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
-
Xellia forms scientific advisory board
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
human-like text from simple prompts. In the healthcare sector, AI’s advancement has begun to impact prescribing, particularly in addressing the growing challenge of antimicrobial resistance.
-
Man vs microbe: the fight against antimicrobial resistance
Antimicrobial resistance (AMR) affects millions of people globally, but addressing AMR poses a unique challenge – as encouraging and promoting manufacturers to invest in research and development of new antibiotics while simultaneously
-
Action on Anti-microbial resistance: Will the UK rise to the challenge
WITHOUT EFFECTIVE AND APPROPRIATE USE OF ANTIMICROBIALS, WE WILL LOSE DECADES OF PROGRESS IN MODERN MEDICINE. ... New antimicrobials will offer limited relief from AMR without matching access and uptake of diagnostics.
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
For years, concerns have been mounting about a problem that has the potential to set our health services back 100 years: the rise of antimicrobial resistance. ... WHO. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Published
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Other recent progress includes NovaBiotics’ novel antimicrobial-immunomodulator, Nylexa, which is now set to enter phase 3 clinical trials in the UK for COVID-19 and non-COVID pneumonia (in hospitalised ... NP432, derived from NovaBiotics’
More from PMHub
Approximately 2 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
